Patents by Inventor Homero Gabriel San Juan Vergara

Homero Gabriel San Juan Vergara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Protein kinase C as a target for the treatment of respiratory syncytial virus
    Publication number: 20090226423
    Abstract: The subject invention concerns a method of inhibiting respiratory syncytial virus (RSV) infection in a patient by decreasing the endogenous protein kinase C (PKC) activity within the patient. Preferably, the preventative and therapeutic methods of the present invention involve administration of a PKC inhibitor. The present inventor has determined that decreasing normal endogenous PKC activity is inhibitory to RSV infection of human cells. The subject invention also pertains to pharmaceutical compositions containing a PKC inhibitor and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: April 3, 2009
    Publication date: September 10, 2009
    Applicant: University of South Florida
    Inventors: Shyam S. Mohapatra, Homero Gabriel San Juan Vergara
  • Protein kinase C as a target for the treatment of respiratory syncytial virus
    Publication number: 20080249057
    Abstract: The subject invention concerns a method of inhibiting respiratory syncytial virus (RSV) infection in a patient by decreasing the endogenous protein kinase C (PKC) activity within the patient. Preferably, the preventative and therapeutic methods of the present invention involve administration of a PKC inhibitor. The present inventor has determined that decreasing normal endogenous PKC activity is inhibitory to RSV infection of human cells. The subject invention also pertains to pharmaceutical compositions containing a PKC inhibitor and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: March 26, 2008
    Publication date: October 9, 2008
    Inventors: Shyam S. Mohapatra, Homero Gabriel San Juan Vergara
  • Protein kinase C as a target for the treatment of respiratory syncytial virus
    Publication number: 20040175384
    Abstract: The subject invention concerns a method of inhibiting respiratory syncytial virus (RSV) infection in a patient by decreasing the endogenous protein kinase C (PKC) activity within the patient. Preferably, the preventative and therapeutic methods of the present invention involve administering a PKC inhibitor, to a patient in need thereof. The present inventor has determined that decreasing normal endogenous PKC activity is inhibitory to RSV infection of human cells. The subject invention also pertains to pharmaceutical compositions containing a PKC,inhibitor and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: December 12, 2003
    Publication date: September 9, 2004
    Inventors: Shyam S. Mohapatra, Homero Gabriel San Juan Vergara